WuXi AppTec Co., Ltd. (WUXAY)
OTCMKTS · Delayed Price · Currency is USD
13.45
-0.79 (-5.55%)
Jul 30, 2025, 1:29 PM EDT
WuXi AppTec Revenue
WuXi AppTec had revenue of 11.14B CNY in the quarter ending June 30, 2025, with 20.37% growth. This brings the company's revenue in the last twelve months to 41.48B, up 11.95% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
41.48B CNY
Revenue Growth
+11.95%
P/S Ratio
6.79
Revenue / Employee
1.05M CNY
Employees
39,414
Market Cap
39.30B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
WuXi AppTec News
- 1 day ago - WuXi AppTec Co., Ltd. (WUXIF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - WuXi AppTec Achieves Strong Growth in Revenue and Profit for Q2 and H1 2025, H1 Revenue from Continuing Operations[1] Up 24.2% YoY, and Adjusted Non-IFRS Net Profit Up 44.4% YoY; Backlog for Continuing Operations Up 37.2% YoY - PRNewsWire
- 19 days ago - WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 - PRNewsWire
- 22 days ago - WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities - PRNewsWire
- 4 weeks ago - WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity - PRNewsWire
- 6 weeks ago - WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets - PRNewsWire
- 6 weeks ago - Focus: China pharma projects disrupted by Sino-US tensions - Reuters
- 6 weeks ago - WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors - PRNewsWire